Objectives: Tetrahydrobiopterin (BH4) is an essential cofactor for endothelial nitric oxide synthase (eNOS) activity. BH4 levels are regulated by de novo biosynthesis; the rate-limiting enzyme is GTP cyclohydrolase I (GTPCH). BH4 activates and promotes homodimerisation of purified eNOS protein, but the intracellular mechanisms underlying BH4-mediated eNOS regulation in endothelial cells remain less clear. We aimed to investigate the role of BH4 levels in intracellular eNOS regulation, by targeting the BH4 synthetic pathway as a novel strategy to modulate intracellular BH4 levels. Methods: We constructed a recombinant adenovirus, AdGCH, encoding human GTPCH. We infected human endothelial cells with AdGCH, investigated the changes in intracellular biopterin levels, and determined the effects on eNOS enzymatic activity, protein levels and dimerisation. Results: GTPCH gene transfer in EAhy926 endothelial cells increased BH4 .10-fold compared with controls (cells alone or control adenovirus infection), and greatly enhanced NO production in a dose-dependent, eNOS-specific manner. We found that eNOS was principally monomeric in control cells, whereas GTPCH gene transfer resulted in a striking increase in eNOS homodimerisation. Furthermore, the total amounts of both native eNOS protein and a recombinant eNOS-GFP fusion protein were significantly increased following GTPCH gene transfer. Conclusions: These findings suggest that GTPCH gene transfer is a valid approach to increase BH4 levels in human endothelial cells, and provide new evidence for the relative importance of different mechanisms underlying BH4-mediated eNOS regulation in intact human endothelial cells. Additionally, these observations suggest that GTPCH may be a rational target to augment endothelial BH4 and normalise eNOS activity in endothelial dysfunction states. 
. Introduction
in endothelial dysfunction is a characteristic feature of vascular disease states, including hypercholesterolemia, Nitric oxide (NO) is generated in the vascular wall by atherosclerosis, diabetes, hypertension and cigarette smokendothelial nitric oxide synthase (eNOS) that oxidises ing [1] . Although NO bioactivity is decreased in dysfunc-L-arginine to L-citrulline using molecular oxygen. NO tional endothelium, levels of eNOS mRNA and protein are plays central roles in maintaining vascular homeostasis, by maintained or even enhanced, but associated with ineffects on endothelial cells, smooth muscle cells, creased NOS-dependent superoxide formation, due to leucocytes and platelets. Impaired NO bioactivity, resulting enzymatic 'uncoupling' of eNOS [2, 3] . Tetrahydrobiopterin (BH4) is an essential cofactor for activity of all NOS enzymes [2, 4] . Intracellular BH4 levels are regulated by the activity of the de novo biosynthetic hMEC (human dermal microvascular endothelial cells), pathway. GTP cyclohydrolase I (GTPCH; EC 3.5. 4.16) and NIH / 3T3 murine fibroblasts were grown in a 5% CO 2 catalyses GTP to dihydroneopterin triphosphate. BH4 is atmosphere in Dulbecco's modified Eagles' medium generated by further steps catalysed by 6-pyruvoltet-(DMEM) supplemented with 10% foetal calf serum (FCS) rahydropterin synthase (PTPS) and sepiapterin reductase (Sigma), 100 U / ml penicillin / streptomycin, and 2 mM [5] . In most cells, the rate limiting enzyme appears to be L-glutamine. For hMEC, medium was also supplemented GTPCH, although some data suggest that in human with 30 ng / ml endothelial growth factor and 4 mg / ml endothelial cells, PTPS may also exert a regulatory role hydrocortisone. For adenoviral infection, cells were grown [6] .
to 70-80% confluence. The monolayers were inoculated The exact role of BH4 in NOS catalysis is still unclear, with virus, diluted in DMEM supplemented with 2% FCS but it appears to facilitate electron transfer from the eNOS for 1 h, then replaced into DMEM containing 10% FCS for reductase domain and maintains the heme prosthetic group 72 h. in its redox active form [4, 7, 8] . Moreover, BH4 is required for promoting and possibly stabilising NOS protein monomers into the active homodimeric form of the enzyme 2 .2. Construction of adenovirus vectors [9, 10] . However, previous studies that have directly investigated the molecular mechanisms of eNOS regulation A 1.2-kb human GTPCH-1 cDNA (kindly provided by by BH4 have focused principally on purified recombinant
Dr. H Ichinose, Japan) [22] was modified by PCR and proteins analysed in cell-free systems [11, 12] . The role and subcloned to incorporate a haemagglutinin (HA) epitope mechanisms of BH4 in regulating eNOS activity in intact tag at the 59 end. The HA-tagged GTPCH cDNA was endothelial cells are less well defined.
cloned into the plasmid pShuttleCMV (kindly provided by Recent studies suggest that reduced BH4 levels may Dr. Bert Vogelstein) [23] and used to generate a recombimediate eNOS uncoupling and that loss of BH4 availabilinant adenovirus, AdGCH, encoding HA-GTPCH under ty in vascular disease states may be an important contrithe control of the cytomegalovirus immediate-early probutor to the loss of NO production leading to endothelial moter, by transfection in 293 cells using the AdEasy dysfunction [2, 13] . Canine basilar artery rings incubated ex system [23] . A recombinant adenovirus, AdeNOS-GFP, vivo with BH4 show augmented NOS-dependent relaxaencoding a C-terminus GFP fusion protein of human eNOS tions. Conversely, rings incubated with the GTPCH inhib-
[24] was generated using the same system, and a recombiitor 2,4-diamino-6-hydroxypyrimidine (DAHP) show renant adenovirus encoding b-galactosidase (AdbGal) was duced NO-dependent relaxations that can be restored by used as a control for viral infection [25] . Viruses were sepiapterin [14] . Similarly, endothelial dysfunction is isolated by three rounds of plaque purification, amplified in improved by supplementation of BH4 in vessel rings from 293 cells, and purified using CsCl gradient ultracentrifugaanimals with atherosclerosis [15] , diabetes [16, 17] or tion, as previously described [25] . hypertension [18] . In humans, BH4 administration appears to augment NO-mediated effects on forearm blood flow in smokers [19] and in patients with diabetes [3, 20] or elevated cholesterol [21] . However, the effects of BH4 on 2 .3. Western blot analysis NO bioactivity observed in these studies may not be entirely mediated through direct modulation of eNOS Cells were lysed in 50 mM Tris-HCl, pH 8, containing activity, because high extracellular BH4 concentrations 0.2% Nonidet P-40, 180 mM NaCl, 0.5 mM EDTA, 100 may result in nonspecific antioxidant effects that indirectly mM phenylmethylsulforyl fluoride, 1 M DTT and protease increase NO bioactivity by superoxide scavenging.
inhibitors (Boerhinger Complete). Equal amounts of celWe sought to investigate the potential utility of a novel lular proteins were resolved by 6 or 12% SDS-PAGE and approach to modulate intracellular BH4 levels in endothelitransferred to PVDF membranes. To investigate eNOS al cells without recourse to pharmacological supplehomodimer formation in endothelial cells, low-temperature mentation using high biopterin concentrations. We used SDS-PAGE was performed as described previously [12] . adenoviral gene transfer of GTPCH to increase the activity Membranes were incubated with either a 1:1000 dilution of of the BH4 de novo biosynthetic pathway, and used this rat anti-HA high affinity monoclonal antibody (Roche), a approach to investigate how intracellular BH4 levels 1:400 dilution of chicken anti-human GTPCH polyclonal regulate eNOS activity, protein levels and dimerisation in antibody (a generous gift of Dr. M Gutlich, Germany), or a intact human endothelial cells.
1:2000 dilution of mouse anti-eNOS monoclonal antibody (Transduction Laboratories). Bands were visualised using chemiluminescence, and quantified using NIH IMAGE soft-2 . Experimental ware. The amount of eNOS-GFP fusion protein in cell lysates was measured by fluorescence as described [24], 2 .1. Cell cultures calculated from a standard curve of purified GFP (Clon-293 cells, the human endothelial cell lines EAhy926 and tech).
.4.
Determination of biopterins in cell lysates and 1 mM), as previously described [28] . We determined NOS culture medium activity by measuring nitrite accumulation in the buffer, in triplicate wells, using a microamperometric assay (NOTwo different HPLC methods were used to determine MkII, World Precision Instruments), expressed as nmol 6 biopterin levels in separate experiments: acid-base oxidanitrite /h/10 cells. tion followed by fluorometric detection, and direct coulometric detection. For fluorometric detection, measure-2 .6. Immunostaining ments of BH4 and dihydrobiopterin (BH2) were performed by HPLC analysis, after iodine oxidation in acidic or Cells, grown on glass coverslips, were washed with alkaline conditions, as previously described [26] . Briefly, PBS, fixed for 10 min with 3% paraformaldehyde concell pellets were lysed in cold extract buffer (50 mM taining 2% glucose, permeablised for 5 min with 0.2% Tris-HCl, pH 7.4, 1 mM DTT, 1 mM EDTA, containing Triton X-100, then blocked for 15 min with 3% BSA. 0.1 mM neopterin as an internal recovery standard).
Primary anti-HA epitope monoclonal antibody was bound Protein concentration was measured using the Bio-Rad for 1 h. Following washes, secondary FITC-conjugated protein assay. Proteins were removed by adding 10 ml of a antibody was added for 15 min. After additional washes, 1:1 mixture of 1.5 M HClO and 2 M H PO to 90 ml of cells were counterstained with propidium iodide and 4 3 4 extracts, followed by centrifugation. To determine total imaged using a Bio-Rad MRC1024 confocal microscope. biopterins (BH4, BH2, biopterin) by acid oxidation 10 ml of 1% iodine in 2% KI solution was added to 90 ml 2 .7. Statistics protein-free supernatant. To determine BH2 and biopterin by alkali oxidation 10 ml of 1 M NaOH was added to 80
Results are expressed as mean6S.D. Statistical signifiml of extract, then 10 ml of iodine / KI solution. Samples cance of differences between means was assessed using were incubated at room temperature for 1 h in the dark.
Students' t-test. A P value ,0.05 was considered statistiAlkaline-oxidation samples were then acidified with 20 ml cally significant. of 1 M H PO . Iodine was reduced by adding 5 ml of fresh 3 4 ascorbic acid (20 mg / ml). HPLC was performed using a Spherisorb ODS-1 column (Waters, Elstree, UK) with a 3 . Results methanol-water (5:95, v / v) mobile phase run at 1 ml / min. Fluorescence detection (350 nm excitation, 450 nm emis-3 .1. Effects of GTPCH gene transfer on GTPCH sion) was performed using an FP-1520 detector (Jasco, expression and intracellular biopterin production Essex, UK). BH4 concentration, expressed as pmol / mg protein, was calculated by subtracting BH21biopterin
We first evaluated the effects of GTPCH gene transfer in from total biopterins. In some experiments, biopterins were human EAhy926 endothelial cells, infected with AdGCH, also measured by HPLC using direct coulometric deor with AdbGal as control, in a series of increasing titres. tection, as described previously [27] . Cells or medium Cell lysates, harvested after 48 h, were analysed by were treated in 0.2 M perchloric acid containing dithioimmunoblotting for recombinant GTPCH protein and by threitol (6.5 mM) and 2.5 mM diethylenetriaminepen-HPLC determination of cellular biopterins. taacetic acid. Following centrifugation (15 000 g for 5
Recombinant GTPCH protein, detected by either antimin) 100 ml of supernatant were analysed by HPLC, and human GTPCH or anti-HA epitope antibodies, increased in biopterins were detected electrochemically using an ESA a dose-dependent fashion after AdGCH infection but was Coulochem detector. The sensitivity of the assays was not detectable in control or AdbGal-transduced cells ( . Levels of total biopterin and BH4 in nontransduced determined in triplicate, and HPLC results were calculated EAhy926 were very low. In contrast, cells transduced with blind to the samples' identity.
AdGCH greatly augmented both total biopterin and BH4, also in a dose-dependent manner, with a 50-fold increase 2 .5. NOS activity assays by nitrite determination in total biopterin levels at a viral multiplicity of infection (MOI) of 100 pfu / cell. Cells were passaged into 12-well plates. After 48 h At very low AdGCH viral titres (,10 MOI) GTPCH incubation, with or without viral infection, the cell monoexpression was below of the detection limit of Western layers were washed three times with Krebs-HEPES buffer blotting. However, AdGCH at these levels still generated a (KHB) (NaCl 99 mM, KCl 4.7 mM, MgSO 1.2 mM, 6-fold increase in biopterin levels compared with nontran-4 KH PO 1.0 mM, CaCl 1.9 mM, NaHCO 25 mM, sduced cells, suggesting that even very low-level GTPCH 2 4 2 3 glucose 11.1 mM, HEPES 20 mM) and were incubated for overexpression is sufficient to significantly augment in-2 h with KHB containing calcium ionophore (A23187; 1 tracellular biopterin levels. mM) and L-arginine (100 mM) in the presence or absence
We further determined total cellular biopterins, BH4 and of the NOS inhibitor N-monomethyl-L-arginine (L-NMMA; neopterin levels in endothelial cell lysates infected with AdGCH or AdbGal (MOI 50), compared with cells periments using two different HPLC methods: acid-base incubated with the synthetic pterin sepiapterin, that eleoxidation followed by fluorometric detection, and by direct vates intracellular BH4 indirectly via the pterin salvage coulometric detection (Table 1 ). Biopterin measurements pathway. We determined biopterin levels in separate exshowed similar differences when determined using either 
low levels of total biopterin, BH2 and BH4 that were in endothelial cells increased more than 10-fold by AdGCH infection. Sepiapterin (10 mM) increased BH4 to levels similar to AdGCH, To investigate the effects of GTPCH overexpression on but total biopterins were even more greatly elevated, such eNOS activity, we measured nitrite production by calcium that BH4 was a much smaller proportion of total biopterins ionophore (A23187)-stimulated endothelial cells. Western (AdGCH 30% vs. sepiapterin ,10%). Changes in biopblot analysis demonstrated that all EAhy926 cells exterins in cell culture media showed changes that correspressed endogenous eNOS protein (Fig. 1) . However, ponded with the changes in cellular levels (Table 1) . In
AdGCH infection greatly augmented eNOS activity (.15 contrast to the striking elevations of BH4 levels following fold) in EAhy926 cells in a dose-dependent fashion (Fig.  GTPCH gene transfer, the levels of neopterin, produced 2). In contrast, eNOS activity in AdbGal transduced cells from the biopterin intermediate between GTPCH and remained at basal levels. Thus, recombinant GTPCH PTPS, remained low, suggesting that PTPS activity was expression in endothelial cells by adenoviral gene transfer not significantly limiting for BH4 biosynthesis despite the results in parallel increases in both intracellular biopterin greatly increased GTPCH activity. levels and eNOS activity. Taken together, these data show that GTPCH overTo further investigate the mechanisms of increased expression by adenoviral gene transfer is highly effective eNOS activity following GTPCH gene transfer, we meain augmenting endothelial cell BH4 levels in a dosesured nitrite production by EAhy296 cells under different dependent fashion. Endothelial cell biosynthesis of BH4 conditions. Increased eNOS activity was abolished by under these conditions does not appear to be limited by the DAHP (3.0 mM), an inhibitor of GTPCH, and by Lactivities of the 'downstream' enzymes PTPS and sepiap-NMMA, an inhibitor of eNOS, despite the presence of terin reductase. Furthermore, GTPCH gene transfer results similar levels of recombinant GTPCH protein and eNOS in a more specific elevation of BH4 in relation to other protein (Fig. 3) . As expected, extracellular sepiapterin cellular biopterins compared with sepiapterin supplesupplementation (10 mM) also increased eNOS activity, mentation.
independent of GTPCH overexpression. However, the magnitude of eNOS activation was not as great as with after AdGCH gene transfer (Fig. 5) . Western blot analysis GTPCH gene transfer despite the very large increase in showed that these variations in nitrite production were total biopterins, possibly reflecting the greater proportion related to the levels of endogenous eNOS protein present of oxidised biopterins produced under these conditions. in the three cell lines (Fig. 5) ; EAhy926 cells have We next investigated the association between GTPCH abundant eNOS, NIH / 3T3 cells do not express eNOS, and overexpression, NO production and eNOS protein, by hMEC cells have low eNOS levels. These data show that comparison of AdGCH gene transfer in EAhy926, hMEC GTPCH gene transfer augments NO production in a and NIH / 3T3 cells, that express eNOS at different levels.
GTPCH-and eNOS-specific manner, and in direct relation Fluorescent immunostaining revealed abundant recombito the levels of endogenous eNOS present in the target cell. nant GTPCH localised in the cytoplasm of all three cell lines after AdGCH infection, but not in control cells (Fig.  3 . 
GTPCH gene transfer promotes eNOS dimerisation 4). Correspondingly, HPLC analysis of cell lysates showed
in endothelial cells that AdGCH gene transfer greatly elevated intracellular biopterin production in all of these cell lines (Table 2 ). In
We next used GTPCH gene transfer to investigate the contrast, nitrite production by AdGCH-transduced hMEC role of BH4 in modulating eNOS dimerisation in living was less than one third that in EAhy926 cells, and in endothelial cells, and to determine the relationships be-NIH / 3T3 cells there was no increase in nitrite production tween eNOS activity, eNOS dimerisation and the total levels of eNOS protein. We used low temperature SDSwas predominantly in the active homodimeric form. Den-PAGE and immunoblotting to investigate eNOS dimerisasitometric quantification of blots from three individual tion in EAhy926 cells, following gene transfer of GTPCH experiments revealed that in AdGCH transduced cells, the (Fig. 6) . In cells incubated with medium alone, or infected total quantity of homodimeric eNOS was increased 3-fold with AdbGal, eNOS was present predominantly as the and the ratio of dimer:monomer band intensities was more 135-kDa monomer, in keeping with the low eNOS activity than two-fold higher than in control cells ( Fig. 6B and C) . previously shown under these conditions (Fig. 6A) . In contrast, eNOS protein in cells transduced with AdGCH, (Fig. 6D) . In view of the potential limitations of than relying on semiquantitative analysis by immunoincreased the total amount of recombinant eNOS-GFP blotting (Table 3 ). In hMEC expressing recombinant protein by approximately one quarter, when quantified eNOS-GFP, GTPCH gene transfer greatly increased directly by GFP fluorescence. Taken together, these findeNOS-GFP dimerisation, and augmented eNOS-GFP ings suggest that adenoviral gene transfer of GTPCH activity, as observed for native eNOS in EAhy296 cells greatly augments BH4 levels and eNOS activity in human (data not shown). In EAhy296 cells, GTPCH gene transfer endothelial cells. This effect is mediated principally by increased enzyme activation and eNOS homodimerisation, but is also associated with a significant increase in total Table 3 eNOS protein quantity. ing proof of principle for future strategies aimed at regulating eNOS activity and function through modulation important action of BH4 in regulating eNOS in endothelial of intracellular BH4 biosynthesis. cells is to maintain eNOS homodimerisation that in turn Several previous studies have established that BH4 is a stabilises the protein and leads to an increase in steadyrequired cofactor for NOS activity. BH4-free NOS is state protein levels. inactive for NO formation; activity is restored by reconOur study has important implications for therapeutic stituting BH4 [9] . Structural studies suggest a role for BH4 strategies aimed at augmenting or normalizing eNOS in heme catalysis and NOS dimerisation [29, 30] . However, activity by increasing intracellular BH4 levels. eNOS most previous functional studies of the role of BH4 in uncoupling in diseased endothelium appears to be an eNOS function have relied on purified recombinant proimportant aspect of endothelial dysfunction in vascular teins in reconstituted cell-free systems. Bovine eNOS disease states, suggesting that increasing BH4 synthesis expressed in E. coli suggested that BH4 was required for could restore eNOS function in conditions such as diabetes eNOS activation by modulation of heme redox function, [17] and atherosclerosis [15] . Indeed, GTPCH overexpresalthough the effect on eNOS homdimerisation appeared to sion in combination with inducible NOS (iNOS) gene be minimal [11] . In another study of recombinant eNOS transfer to vein grafts appeared to increase NOS activity purified from a baculovirus system, exogenously added [34] , although it was not clear whether recombinant BH4 increased both eNOS activity and dimerisation [31] .
.4. GTPCH gene transfer increases total eNOS protein levels in endothelial cells
GTPCH led to the expected increase in BH4 levels, or However, in none of these studies was it possible to whether other mechanism(s) may have contributed-for address the functional importance of BH4 in intracellular example, increased iNOS expression due to the effects of eNOS regulation, where eNOS is subject to a host of other viral coinfection. Our studies in human endothelial cells regulatory mechanisms including membrane association now provide more definitive proof-of-principle that strateand subcellular trafficking, phosphorylation and proteingies targeting the intracellular BH4 biosynthetic pathway protein interactions [32] . Our data now suggest that in are a rational and effective approach to augment BH4 intact human endothelial cells eNOS dimerisation is an levels in endothelial cells, and that this has specific effects important regulator of BH4-mediated eNOS activation.
on eNOS activity and regulation. This approach avoids the Since we used human endothelial cell lines, further studies potential nonspecific effects of high-level extracellular are needed in primary cell cultures and in endothelial cells biopterin supplementation, that may increase NO bioactiviisolated from disease states, where absolute levels of BH4 ty, but do so by simple removal of superoxide anions and eNOS protein may be different. However, our experirather than any specific effect on NOS activity or regulaments with both native eNOS and recombinant eNOStion. Furthermore, these effects of BH4 supplementation GFP fusion proteins allowed us to investigate the relative are unpredictable, as high concentrations of this redoxcontribution of these factors to the overall increase in active compound can be pro-oxidant, leading directly to eNOS activity in this model system. GTPCH gene transfer superoxide generation that reduces NO bioactivity [35, 36] . increased total eNOS activity in EAhy296 10-fold; the GTPCH gene transfer results in a proportionately greater quantity of dimerised eNOS was increased 3-fold and total increase in the BH4 fraction compared with the elevation eNOS protein levels were increased by 25%. These in total biopterins, including the oxidised form BH2, than observations suggest that the principal action of BH4 in results from pharmacologic supplementation using sepiapintact endothelial cells is to increase the enzymatic specific terin. This observation has potentially important implicaactivity of eNOS. This is accompanied by eNOS homotions for studies of eNOS regulation, as BH2 is inactive for dimerisation, and by a modest but significant increase in eNOS activation and may compete with BH4 for eNOS total eNOS protein levels.
binding and worsen eNOS uncoupling [15, 17] . We meaOur observation of increased eNOS protein levels in sured biopterins using two separate assay systems: difresponse to increased BH4 levels in endothelial cells ferential acid-base oxidation with fluorometric detection suggests a novel aspect of intracellular eNOS regulation by and by direct coulometric detection [26, 27] . Both assays BH4. This observation may reflect increased stability of gave very similar results, although quantification of the the eNOS homodimer compared with the BH4-deficient BH2 fraction in conditions of very high pharmacologic monomer. Indeed, recent studies suggest that the neuronal biopterin supplementation, using sepiapterin, tended to be NOS (nNOS) homodimer is more stable than free monounderestimated by the differential oxidation method. This mers, resulting in proteolytic degradation of monomers is likely due to the known limitations of this method in the [32, 33] . Our findings now raise the possibility that an efficiency of oxidation [5, 26] . Similarly, the absolute 
